| Value | ₹0.44 Cr |
|---|---|
| Execution period | Vesting after 1 year; 8 year exercise window |
NSE filing, NSE: FUSION. Summary written from the filing by ALFA Finder's alert engine.
Fusion Finance Ltd: key numbers
- Share price
- ₹135.19
- Market cap
- ₹2,186 Cr
- Revenue (annual)
- ₹1,699 Cr
- Net profit (annual)
- ₹13.85 Cr
- P/E (TTM)
- 13.0×Sector 19.7×
- Promoter holding
- 51.76%-2.20% QoQ
- FII holding
- 5.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fusion Finance Ltd
All →Fusion Finance Board Meeting Date
Fusion Finance has scheduled a board meeting on 02 Nov 2026 to approve Q1/H1 FY27 standalone results. The trading window will re-open 48 hours after results declaration.
Fusion Finance Other Announcement
Fusion Finance Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Fusion Finance Other Announcement
Designated Person Pooja Mehta acquired 22,854 shares of Fusion Finance Ltd via ESOP allotment. The transaction is valued at ₹0.35 Crore.
- Value
- ₹0.35 Cr
Fusion Finance Other Announcement
Fusion Finance Ltd filed routine quarterly details of its Compliance Officer and RTA under LODR. No business transaction or material event is disclosed.
Fusion Finance Other Announcement
Connected person Devesh Sachdev sold 800,000 equity shares of Fusion Finance for ₹13.61 Crore through a market sale. This is a standard PIT disclosure filing.
- Value
- ₹13.61 Cr
Fusion Finance Employee Stock Options
Fusion Finance Limited has allotted 10,00,000 equity shares to its ESOP Trust, pursuant to the employee stock option plan approved earlier.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date